'Queer Eye's Jonathan Van Ness Makes Honest 'Confession' About Weight Loss Drug Use
Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...
News Medical on MSN23h
Statistical model analyzes the cost-effectiveness of semaglutide for non-diabetic obese individuals
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.
Semaglutide currently not cost-effective for heart patients without diabetes, study finds
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...
lifesciencesweden.se7h
Life science trends 2025 – Part 1 obesity drugs
More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.
Medscape7h
Are Patients On GLP-1s Getting the Right Nutrients?
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
grocerydive23h
How grocers can appeal to consumers taking GLP-1s
As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.